<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
Form 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON THE NASDAQ STOCK MARKET
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
AND RULE 13a-17 OR 15d-17 THEREUNDER
DURA PHARMACEUTICALS, INC.
(Exact name of issuer as specified in its charter)
5880 Pacific Center Blvd. San Diego, CA 92121
(Address of Principal Executive Offices)
(619) 457-2553
(Issuer's telephone number including area code)
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of Security Common Stock
------------------------------------------------------
2. Number of shares outstanding before the change 16,097,118
-------------------------
3. Number of shares outstanding after the change 18,799,618
--------------------------
4. Effective date of change: May 29, 1996
---------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury
etc.) Secondary Public Offering
------------------------------------------------------------------
Give brief description of transaction On May 29, 1996, the Issuer completed a
------------------------------------------
public offering of 2,702,500 shares of Common Stock at $58.75 per share, which
- -------------------------------------------------------------------------------
included 352,500 shares at $58.75 per share pursuant to the exercise of the
- -------------------------------------------------------------------------------
underwriters' over-allotment option.
- -------------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
---------------------------------------------------
2. Name after change
------------------------------------------------------
3. Effective date of charter amendment changing name
----------------------
4. Date of shareholder approval of change, if required
--------------------
Dated: May 29, 1996 /s/ MITCHELL R. WOODBURY
-------------------------------------
Mitchell R. Woodbury
Vice President, General Counsel
and Secretary
